|
Original paper
Suppression of popping rates in radiofrequency ablation under perfluorobutane microbubbles for hepatocellular carcinoma
- Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan
- Department of Clinical Engineering, Saiseikai Niigata Hospital, Niigata, Japan
Clin Exp HEPATOL 2024; 10, 4:
Online publish date: 2024/12/12
Get citation
PlumX metrics:
1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-249. 2.
European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2018; 69: 182-236. 3.
Mori Y, Tamai H, Shingaki N, et al. Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma. Hepatol Int 2009; 3: 509-515. 4.
Kang TW, Lim HK, Lee MW, et al. Aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation: risk factors and clinical significance. Radiology 2015; 276: 274-285. 5.
Takada Y, Kurata M, Ohkohchi N. Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma. Int J Clin Oncol 2003; 8: 332-335. 6.
Pua U: Rapid intra-hepatic dissemination of hepatocellular carcinoma with pulmonary metastases following combined loco-regional therapy. Korean J Radiol 2013; 14: 640-642. 7.
Choe J, Kim KW, Kim YI, et al. Feasibility of a low-power radiofrequency ablation protocol to delay steam popping. J Vasc Interv Radiol 2016; 27: 268-274. 8.
Kotoh K, Nakamuta M, Morizono S, et al. A multi-step, incremental expansion method for radio frequency ablation: optimization of the procedure to prevent increases in intra-tumor pressure and to reduce the ablation time. Liver Int 2005; 25: 542-547. 9.
Min JH, Lim HK, Lim S, et al. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US. Clin Mol Hepatol 2014; 20: 61-70. 10.
Min JH, Kim YS, Rhim H, et al. Effect of parenchymal uptake of perfluorobutane microbubbles (Sonazoid®) on radiofrequency ablation of the liver: in vivo experimental study. Liver Int 2016; 36: 1187-1195. 11.
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 2013; 48: 452-458. 12.
Livraghi T, Goldberg SN, Lazzaroni S, et al. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 655-661. 13.
Fernandes ML, Lin CC, Lin CJ, et al. Prospective study of a ‘popping’ sound during percutaneous radiofrequency ablation for hepatocellular carcinoma. J Vasc Interv Radiol 2010; 21: 237-244. 14.
Iida H, Aihara T, Ikuta S, et al. Effectiveness of impedance monitoring during radiofrequency ablation for predicting popping. World J Gastroenterol 2012; 18: 5870-5878. 15.
Angonese C, Baldan A, Cillo U, et al. Complications of radiofrequency thermal ablation in hepatocellular carcinoma: what about “explosive” spread? Gut 2006; 55: 435-436. 16.
Song KD, Lim HK, Rhim H, et al. Hepatic resection vs percutaneous radiofrequency ablation of hepatocellular carcinoma abutting right diaphragm. World J Gastrointest Oncol 2019; 11: 227-237.
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
|
|
